Skip Navigation


European Heart Journal Advance Access originally published online on October 4, 2005
European Heart Journal 2005 26(22):2472-2473; doi:10.1093/eurheartj/ehi550
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/22/2472-a    most recent
ehi550v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gasparini, M.
Right arrow Articles by Breithardt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gasparini, M.
Right arrow Articles by Breithardt, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Indications to implantable cardioverter defibrillator in heart failure patients: a comment on the recently released ESC Guidelines on treatment and diagnosis of heart failure

Maurizio Gasparini

Electrophysiology and Pacing Unit
IRCCS Istituto Clinico Humanitas
Rozzano-Milano
Italy
Tel: +39 0 282244622
Fax: +39 0 282244693
E-mail address
: maurizio.gasparini@humanitas.it

Günter Breithardt

Medizinischen Klinik und Poliklinik C
Kardiologie/Angiologie
Universitätsklinikum Münster
D-48129 Münster
Germany
Tel: +49 251 83 4 7617
Fax: +49 251 83 4 7864
E-mail address: g.breithardt@uni-muenster.de

The first 10% of the full text of this article appears below.

We read with great interest the recently published ESC Guidelines on the diagnosis and treatment of heart failure.1 Particularly noteworthy were the recommendations that up-dated the indications for implantable cardioverter defibrillators (ICD) in heart failure patients (p. 1132). The three specific recommendations took into account the recently released clinical evidence of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?